Pulmonary microRNA profiling: implications in upper lobe predominant lung disease

Por Armstrong, David A., Nymon, Amanda B., Ringelberg, Carol S., Lesseur, Corina, Hazlett, Haley F., Howard, Louisa, Marsit, Carmen J., Ashare, Alix
Publicado no Clin Epigenetics (2017)

Indoleamine 2,3-Dioxgenase 1 (IDO1) Inhibitors Activate The Aryl Hydrocarbon Receptor

Por Moyer, Benjamin J., Rojas, Itzel Y., Murray, Iain A., Lee, Seokwon, Hazlett, Haley F., Perdew, Gary H., Tomlinson, Craig R.
Publicado no Toxicol Appl Pharmacol (2017)

Pre-Analytical Handling Conditions and Small RNA Recovery from Urine for miRNA Profiling

Por Armstrong, David A., Dessaint, John A., Ringelberg, Carol S., Hazlett, Haley F., Howard, Louisa, Abdalla, Moemen A.K., Barnaby, Roxanna L., Stanton, Bruce A., Cervinski, Mark A., Ashare, Alix
Publicado no J Mol Diagn (2018)

Genome-wide DNA methylation profiling shows a distinct epigenetic signature associated with lung macrophages in cystic fibrosis

Por Chen, Youdinghuan, Armstrong, David A., Salas, Lucas A., Hazlett, Haley F., Nymon, Amanda B., Dessaint, John A., Aridgides, Daniel S., Mellinger, Diane L., Liu, Xiaoying, Christensen, Brock C., Ashare, Alix
Publicado no Clin Epigenetics (2018)

Inhibition of the Aryl Hydrocarbon Receptor Prevents Western Diet-Induced Obesity. Model for AHR Activation by Kynurenine via Oxidized-LDL, TLR2/4, TGFβ, and IDO1

Por Moyer, Benjamin J., Rojas, Itzel Y., Kerley-Hamilton, Joanna S., Hazlett, Haley F., Nemani, Krishnamurthy V., Trask, Heidi W., West, Rachel J., Lupien, Leslie E., Collins, Alan J., Ringelberg, Carol S., Gimi, Barjor, Kinlaw, William B., Tomlinson, Craig R.
Publicado no Toxicol Appl Pharmacol (2016)